glp 1 and intracranial hypertension Effect of glucagon like peptide-1 receptor agonist exenatide, used as an pressure lowering agent, on cognition in Idiopathic Intracranial Infographic: Landmark trials in Neuro-Ophthalmology—results

Future Research Directions and Considerations Despite the intriguing characteristics proposed for Fragment 176-191, Mod GRF 1-29, and Ipamorelin, further research is necessary to delineate their precise mechanisms of interaction

doi: 10.1016/j.peptides.2009.07.012 81 BischofJMvan der PloegLHTColmersWFWevrickR

Fasting Regimen: Utilize the "Fasting Tracker" in the Healthy Habits Tracker mobile app Search in the app store, download, enter your Health Professional's OHS Code - if you do not have a Health Professional's code, use code FITNESS

Patients considering GLP-1 discontinuation should work closely with their healthcare team to develop individualized maintenance plans, establish realistic expectations about weight trajectory, and implement close monitoring for weight regain

N.HelmchenF